Fennec Pharmaceuticals Inc. Income Statement

Income Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 0.18M0.27M0.20M-0.13M1.77M21.25M47.54M
Cost of Revenue 2.79M12.12M18.43M
Gross Profit 1.45M19.99M29.11M
Operating items
Research & Development 2.11M65.60M1.49M2.08M0.60M0.36M0.26M0.47M1.94M5.01M5.61M5.11M4.98M3.53M0.06M0.31M
Selling, General & Administrative 1.21M3.90M1.94M1.54M1.33M2.52M1.63M2.40M5.01M5.40M7.40M12.95M12.24M17.72M20.59M23.05M
Other Operating Expenses -1.28M-1.28M0.04M2.79M13.38M21.61M
Operating Expenses 3.33M69.49M3.44M3.62M1.93M2.88M1.89M2.87M6.95M10.41M13.01M18.05M17.22M24.04M34.02M44.97M
Operating Income -3.44M-3.62M-1.93M-2.88M-1.89M-2.87M-6.95M-10.41M-13.01M-17.89M-17.22M-22.59M-12.77M2.57M
EBIT -3.44M-3.62M-1.93M-2.88M-1.89M-2.87M-6.95M-10.41M-13.01M-17.89M-17.22M-22.59M-12.77M2.57M
Non-operating items
Non Operating Investment Income 8.07M-1.56M0.35M
Interest & Investment Income 0.04M0.03M0.00M0.00M0.00M0.01M0.05M0.35M0.32M0.09M0.05M0.20M0.44M1.68M
Other Non Operating Income 0.01M-0.01M3.78M0.35M1.24M0.05M-0.13M0.17M-0.02M-0.01M-0.01M-0.01M0.01M-0.08M
Non Operating Income 8.12M-1.54M3.78M0.70M1.23M0.08M-0.10M0.52M0.23M-0.22M-0.12M-1.12M-3.27M-2.64M
Net income details
EBT -3.40M-3.60M-1.93M-2.88M-1.89M-2.86M-6.90M-10.06M-12.69M-17.81M-17.30M-23.37M-16.05M-0.07M
Tax Provisions 0.36M
Profit After Tax -3.01M-7.82M4.68M-5.16M1.84M-2.18M-0.66M-2.79M-7.05M-9.89M-12.69M-17.81M-17.30M-23.71M-16.05M-0.44M
Income from Continuing Operations -3.40M-3.60M-1.93M-2.88M-1.89M-2.86M-6.90M-10.06M-12.69M-17.81M-17.30M-23.37M-16.05M-0.44M
Consolidated Net Income -3.40M-3.60M-1.93M-2.88M-1.89M-2.86M-6.90M-10.06M-12.69M-17.81M-17.30M-23.37M-16.05M-0.44M
Income towards Parent Company -3.40M-3.60M-1.93M-2.88M-1.89M-2.86M-6.90M-10.06M-12.69M-17.81M-17.30M-23.37M-16.05M-0.44M
Net Income towards Common Stockholders -3.40M-3.60M-1.93M-2.88M-1.89M-2.86M-6.90M-10.06M-12.69M-17.81M-17.30M-23.37M-16.05M-0.44M
Additional items
EPS (Basic) 0.20-0.210.19-0.22-0.06-0.22-0.47-0.52-0.64-0.76-0.67-0.90-0.60-0.02
EPS (Weighted Average and Diluted) 0.19-0.210.17-0.22-0.76-0.67-0.90-0.60-0.02
Shares Outstanding (Weighted Average) 8.39M8.39M8.39M9.86M10.94M13.64M15.87M19.73M19.90M25.81M26.01M26.24M26.63M27.43M
Shares Outstanding (Diluted Average) 0.02M25.16M31.71M9.87M0.02M26.27M26.57M27.29M
EBITDA 3.01M-7.82M-3.44M-5.16M1.84M-2.88M-1.89M-2.87M-6.95M-10.41M-13.01M-17.89M-17.22M-22.59M-12.77M2.57M
Interest Expenses -0.02M-0.02M0.01M0.13M0.98M3.39M4.07M